Free Trial

Smith & Nephew (SNN) Competitors

Smith & Nephew logo
$25.32 +0.28 (+1.12%)
(As of 11/22/2024 ET)

SNN vs. ZBH, SOLV, PEN, GKOS, BLCO, INSP, PRCT, NVST, AXNX, and NARI

Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Envista (NVST), Axonics (AXNX), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry.

Smith & Nephew vs.

Smith & Nephew (NYSE:SNN) and Zimmer Biomet (NYSE:ZBH) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, community ranking, analyst recommendations, earnings and institutional ownership.

Zimmer Biomet has higher revenue and earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & Nephew$5.55B1.99$263M$1.9712.85
Zimmer Biomet$7.39B2.97$1.02B$5.2620.96

25.6% of Smith & Nephew shares are held by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are held by institutional investors. 1.0% of Smith & Nephew shares are held by insiders. Comparatively, 1.0% of Zimmer Biomet shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Zimmer Biomet had 24 more articles in the media than Smith & Nephew. MarketBeat recorded 24 mentions for Zimmer Biomet and 0 mentions for Smith & Nephew. Zimmer Biomet's average media sentiment score of 1.06 beat Smith & Nephew's score of 0.00 indicating that Zimmer Biomet is being referred to more favorably in the news media.

Company Overall Sentiment
Smith & Nephew Neutral
Zimmer Biomet Positive

Smith & Nephew has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.

Zimmer Biomet has a net margin of 14.27% compared to Smith & Nephew's net margin of 0.00%. Zimmer Biomet's return on equity of 12.95% beat Smith & Nephew's return on equity.

Company Net Margins Return on Equity Return on Assets
Smith & NephewN/A N/A N/A
Zimmer Biomet 14.27%12.95%7.55%

Zimmer Biomet received 451 more outperform votes than Smith & Nephew when rated by MarketBeat users. Likewise, 67.24% of users gave Zimmer Biomet an outperform vote while only 54.43% of users gave Smith & Nephew an outperform vote.

CompanyUnderperformOutperform
Smith & NephewOutperform Votes
448
54.43%
Underperform Votes
375
45.57%
Zimmer BiometOutperform Votes
899
67.24%
Underperform Votes
438
32.76%

Zimmer Biomet has a consensus price target of $123.22, suggesting a potential upside of 11.79%. Given Zimmer Biomet's higher probable upside, analysts plainly believe Zimmer Biomet is more favorable than Smith & Nephew.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith & Nephew
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
Zimmer Biomet
2 Sell rating(s)
12 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.20

Smith & Nephew pays an annual dividend of $0.55 per share and has a dividend yield of 2.2%. Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. Smith & Nephew pays out 27.9% of its earnings in the form of a dividend. Zimmer Biomet pays out 18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Zimmer Biomet beats Smith & Nephew on 17 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNN vs. The Competition

MetricSmith & NephewSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$11.07B$10.30B$5.38B$20.14B
Dividend Yield2.14%1.10%5.13%3.50%
P/E Ratio12.8524.12105.1444.57
Price / Sales1.9930.171,233.1517.74
Price / Cash7.9423.2340.4121.28
Price / Book2.124.947.094.71
Net Income$263M$182.72M$119.65M$986.85M
7 Day Performance1.73%6.33%2.25%3.76%
1 Month Performance-13.38%-0.07%-2.33%4.65%
1 Year Performance-1.40%-1.91%33.98%27.72%

Smith & Nephew Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNN
Smith & Nephew
3.2211 of 5 stars
$25.32
+1.1%
N/A-1.4%$11.07B$5.55B12.8518,452
ZBH
Zimmer Biomet
4.7528 of 5 stars
$108.40
-0.8%
$123.22
+13.7%
-3.2%$21.75B$7.60B20.6118,000Analyst Revision
Positive News
SOLV
Solventum
1.6383 of 5 stars
$69.63
+1.8%
$68.00
-2.3%
N/A$12.03BN/A0.0022,000
PEN
Penumbra
4.2737 of 5 stars
$240.15
+0.4%
$227.92
-5.1%
+5.7%$9.22B$1.16B278.144,200Analyst Forecast
Insider Trade
News Coverage
GKOS
Glaukos
3.8616 of 5 stars
$140.95
-0.3%
$134.55
-4.5%
+128.4%$7.77B$360.35M-46.90780News Coverage
Positive News
BLCO
Bausch + Lomb
2.3317 of 5 stars
$19.81
+2.2%
$20.91
+5.5%
+28.2%$6.98B$4.15B-18.8713,300
INSP
Inspire Medical Systems
4.7564 of 5 stars
$186.19
+0.8%
$233.58
+25.5%
+31.0%$5.58B$624.80M172.781,011Analyst Upgrade
Positive News
PRCT
PROCEPT BioRobotics
1.5908 of 5 stars
$94.45
+1.9%
$89.50
-5.2%
+169.7%$4.93B$136.19M-48.89626Insider Trade
NVST
Envista
3.6756 of 5 stars
$21.39
+5.0%
$20.71
-3.2%
-10.4%$3.68B$2.57B-2.7512,800
AXNX
Axonics
3.2771 of 5 stars
$70.98
flat
$71.00
+0.0%
N/A$3.63B$366.38M-591.45610
NARI
Inari Medical
3.2798 of 5 stars
$49.80
+1.6%
$58.89
+18.3%
-15.9%$2.92B$493.63M-37.071,300Insider Trade

Related Companies and Tools


This page (NYSE:SNN) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners